SARS-antibody-80R-(IgG) |
|||
E24CHA001 | EnoGene | Human-,-Human-IgG1. | EUR 276.5 |
Description: Human, Human IgG1. |
Human IgG antibody Laboratories manufactures the recombinant protein sars-cov3 reagents distributed by Genprice. The Recombinant Protein Sars-Cov3 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Recombinant products are available in stock. Specificity: Recombinant Category: Protein Group: Sars-Cov3
JBS True Blue |
||
MiTeGen | 300 µl | EUR 16 |
Description: JBS True Blue |
True Blue Chloride |
||
Toronto Research Chemicals | 100mg | EUR 11200 |
Description: 71431-30-6 |
Mouse Monoclonal Anti-SARS Spike Protein IgG |
||
Alpha Diagnostics | 20 ug | EUR 489.6 |
Mouse Monoclonal Anti-SARS Nucleocapsid protein IgG |
||
Alpha Diagnostics | 50 ug | EUR 562.8 |
Mouse Monoclonal Anti-SARS Nucleocapsid Protein IgG |
||
Alpha Diagnostics | 50 ug | EUR 562.8 |
SARS Coronavirus IgG ELISA Kit |
||
Creative Diagnostics | 96T | EUR 2590.8 |
Description: For the qualitative determination of IgG class antibodies against SARS Coronavirus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by SARS Coronavirus. |
Human SARS-CoV-2 Spike Protein S1 IgG (S1-IgG) ELISA Kit |
||
Sunlong | 96 Tests | EUR 468 |
SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein |
|||
10-416 | ProSci | 0.1 mg | EUR 651.3 |
Description: The Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV) is an enveloped, positive-stranded RNA viruses that can cause a severe respiratory disease. Its genome consists of a ∼30 kb linear, non-segmented, capped, polycistronic, polyadenylated RNA molecule, the first two-third of which is directly translated into two large polyproteins. These two polypeptides are processed into 16 non-structural proteins (nsps), forming the replicase complex, which is active in the cytoplasm in close association with cellular membranes. Nsp1 was proved to be able to suppress host gene expression by promoting host mRNA degradation and was involved in cellular chemokine deregulation. This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus- and interferon (IFN)-dependent signaling. Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses. |
SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein |
|||
10-417 | ProSci | 0.1 mg | EUR 651.3 |
Description: May participate in viral replication by acting as a ssRNA-binding protein. |
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein |
|||
10-425 | ProSci | 0.1 mg | EUR 651.3 |
Description: The positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins incorporate 16 protein domains (nsps). The putative non-structural protein 2 (nsp2) of SARS-CoV plays an important role in viral transcription and replication, and is an attractive target for anti-SARS drug development. |
SARS-CoV-2 (COVID-19) ORF8 Recombinant protein |
|||
10-436 | ProSci | 0.1 mg | EUR 695.4 |
Description: May play a role in host-virus interaction. |
SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein |
|||
10-002 | ProSci | 0.1 mg | EUR 714.3 |
Description: LOCUS: QHD43422 121aa linear VRL 18-MAR-2020 |
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein |
|||
20-187 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein |
|||
20-188 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein |
SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein |
|||
20-192 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein |
|||
20-212 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein |
|||
20-213 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein |
|||
20-214 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein |
|||
20-215 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein |
|||
20-217 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein |
|||
20-218 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein |
SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein |
|||
20-237 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein |
|||
20-250 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein |
SARS-CoV-2 (COVID-19) NSP10 Recombinant Protein |
|||
10-408 | ProSci | 0.1 mg | EUR 651.3 |
Description: Nsp10 have shown that it is a 15-kDa protein of unknown function that has been shown to interact with itself, nsp1, and nsp7. It colocalizes with N to sites of viral replication and is essential for replication. It plays a pivotal role in viral transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16 2'-O-methyltransferase activities. Therefore plays an essential role in viral mRNAs cap methylation. Nsp10 is a critical regulator of coronavirus RNA synthesis and may play an important role in polyprotein processing. |